Revita DMR
Obesity (Weight Maintenance Post-GLP-1)
Key Facts
Indication
Obesity (Weight Maintenance Post-GLP-1)
Phase
Pivotal
Status
Active, Enrolling
Company
About Fractyl Health
Fractyl Health's mission is to prevent, reverse, and eradicate obesity and type 2 diabetes by developing durable, organ-targeted therapies that address root causes rather than symptoms. Its key achievement is the development of the Revita DMR system, an outpatient endoscopic procedure with positive clinical data for weight maintenance post-GLP-1 therapy, now in a pivotal U.S. study (REMAIN-1). The company's strategy is built on two complementary platforms: the near-term, device-based Revita and the long-term, gene therapy-based Rejuva, aiming to shift metabolic disease treatment from chronic management to potential one-time cures.
View full company profile